OAKLAND, Ca. -- Directors of the California stem cell agency today approved $16 million for two clinical trials involving AIDS lymphoma and another involving a rare genetic affliction that creates immune deficiencies problems.
Names of the recipients were not immediately disclosed. See this item for more information on the awards.
No comments:
Post a Comment